Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
39.18
1.06 (2.78%)
At close: Aug 22, 2025, 2:20 PM

Caris Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q2 2024 Q1 2024 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Jun 30, 2024 Mar 31, 2024 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
181.4M 120.92M 100.05M 80.68M 100.83M 85.69M 80.8M
Cost of Revenue
67.71M 63.85M 62.49M 54.56M 46.74M 42.83M 42.21M
Gross Profit
113.69M 57.06M 37.55M 26.11M 54.09M 42.87M 38.59M
Operating Income
17.99M -57.95M 67.01M -92.22M 66.44M 50.84M 48.76M
Interest Income
1.62M 503K 2.64M 1.77M n/a n/a n/a
Pretax Income
-71.79M -102.58M -66.19M -111.03M 54.83M 39.8M 37.18M
Net Income
-71.79M -102.58M -66.19M -111.03M 51.16M 37.94M 35.74M
Selling & General & Admin
106.63M 91.95M 79.78M 83.96M 12.29M 10.17M 7.74M
Research & Development
25.05M 23.07M 24.79M 34.38M n/a n/a n/a
Other Expenses
-35.98M 1K -134.02M n/a n/a n/a n/a
Operating Expenses
95.7M 115.02M -29.46M 118.34M 12.29M 10.17M 7.74M
Interest Expense
19.21M 12.78M 13.67M 9.29M n/a 11.11M 11.17M
Selling & Marketing Expenses
42.26M 38.59M 38.71M 38.49M n/a n/a n/a
Cost & Expenses
163.41M 178.87M 33.04M 172.9M 59.03M 53M 49.95M
Income Tax Expense
n/a n/a n/a n/a 3.68M 1.86M 2.5M
Shares Outstanding (Basic)
64.92M 254.79M 254.79M 254.79M 17.34M 17.28M 17.27M
Shares Outstanding (Diluted)
64.92M 254.79M 254.79M 254.79M 17.53M 17.48M 17.52M
EPS (Basic)
-7.97 -0.4 -0.35 -0.53 2.95 2.20 2.07
EPS (Diluted)
-7.97 -0.4 -0.35 -0.53 2.92 2.17 2.04
EBITDA
-46.17M -82.75M -40.9M -84.03M 87.72M 80.39M 78.18M
EBIT
-52.58M -89.8M -52.51M -101.74M n/a 50.91M 48.35M
Depreciation & Amortization
6.41M 7.04M 11.61M 17.7M 32.88M 29.48M 28.77M